Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.31 |
| ▸ | IDO1 | P14902 | 1/20 | 0.31 |
| ▸ | HTR6 | P50406 | 1/20 | 0.30 |
| ▸ | HTR2A | P28223 | 3/20 | 0.30 |
| ▸ | RET | P07949 | 1/20 | 0.30 |
| ▸ | HTR2C | P28335 | 1/20 | 0.30 |
| ▸ | HRH1 | P35367 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17061157 | 0.83 | NOTUM (0.33) | HTR6HTR2ARETHTR2CHRH1 | |
| SCHEMBL8367488 | 0.77 | HTR2A (0.34) | HTR2AHTR2CHRH1 | |
| SCHEMBL7950524 | 0.77 | MTNR1A (0.33) | HTR6HTR2ARETHTR2CHRH1 | |
| SCHEMBL16061146 | 0.77 | HTR2A (0.42) | HTR2A | |
| Hydrochloric Acid SCHEMBL29960643 | 0.76 | HTR2A (0.46) | MEN1KMT2AHTR2ARETHTR2C | |
| SCHEMBL29960263 | 0.75 | HTR2A (0.47) | HTR6HTR2ARETHTR2CHRH1 | |
| SCHEMBL627090 | 0.74 | HTR6 (0.50) | IDO1HTR6HTR2ARET | |
| SCHEMBL300098 | 0.74 | NOTUM (0.32) | HTR2A | |
| SCHEMBL19852205 | 0.73 | NOTUM (0.33) | SIGMAR1HTR6HTR2ARETHTR2C | |
| SCHEMBL24115366 | 0.72 | PSMB5 (0.41) | MEN1KMT2AHTR2AHTR2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022204150-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CNS DISORDERS | BLUE OAK PHARMACEUTICALS, INC. (US) | 2022-09-29 | — | — | WO | disclosed |